BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 33126510)

  • 1. Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential.
    Stackhouse CT; Gillespie GY; Willey CD
    Cells; 2020 Oct; 9(11):. PubMed ID: 33126510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
    Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z
    Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
    Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
    Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
    Front Immunol; 2021; 12():706936. PubMed ID: 34899682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between
    Stevanovic M; Kovacevic-Grujicic N; Petrovic I; Drakulic D; Milivojevic M; Mojsin M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
    Zhang K; Li Q; Kang X; Wang Y; Wang S
    Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
    Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
    Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dysregulation of Long Non-coding RNAs in Glioblastoma Multiforme and Their Study Through Use of Modern Molecular-Genetic Approaches].
    Večeřa M; Šána J; Bútová R; Reguli Š; Hermanová M; Křen L; Lipina R; Smrčka M; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):168-170. PubMed ID: 29808696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
    Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
    Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
    Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targets.
    Yadav G; Kulshreshtha R
    J Cell Physiol; 2022 Jan; 237(1):401-420. PubMed ID: 34533835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
    Ji J; Zhao L; Zhao X; Li Q; An Y; Li L; Li D
    Int J Mol Med; 2020 Jul; 46(1):224-238. PubMed ID: 32319552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets.
    Hazra R; Utama R; Naik P; Dobin A; Spector DL
    Stem Cell Reports; 2023 Nov; 18(11):2056-2070. PubMed ID: 37922916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
    Li Q; Yu Q; Ji J; Wang P; Li D
    Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
    Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
    J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.